Navigation Links
UConn chemists find secret to increasing luminescence efficiency of carbon nanotubes
Date:3/6/2009

STORRS, Conn. - Chemists at the University of Connecticut have found a way to greatly increase the luminescence efficiency of single-walled carbon nanotubes, a discovery that could have significant applications in medical imaging and other areas.

Increasing the luminescence efficiency of carbon nanotubes may someday make it possible for doctors to inject patients with microscopic nanotubes to detect tumors, arterial blockages and other internal problems. Rather than relying on potentially harmful x-rays or the use of radioactive dyes, physicians could simply scan patients with an infrared light that would capture a very sharp resolution of the luminescence of the nanotubes in problem areas.

UConn's process of increasing the luminescence efficiency of single-walled carbon nanotubes will be featured in Science magazine on Friday, March 6, 2009. The research was performed in the Nanomaterials Optoelectronics Laboratory at the Institute of Materials Science at the University of Connecticut, in Storrs, CT. A patent for the process is pending.

University of Connecticut Chemist Fotios Papadimitrakopoulos describes the discovery as a major breakthrough and one of the most significant discoveries in his 10 years of working with single-walled carbon nanotubes. Assisting Papadimitrakopoulos with the research were Polymer Program graduate student Sang-Yong Ju (now a researcher at Cornell University) and William P. Kopcha, a former Chemistry undergraduate assistant in the College of Liberal Arts and Sciences who is now a first-year graduate student at UConn.

Although carbon is used in many diverse applications, scientists have long been stymied by the element's limited ability to emit light. The best scientists have been able to do with solution-suspended carbon nanotubes was to raise their luminescence efficiency to about one-half of one percent, which is extremely low compared to other materials, such as quantum dots and quant
'/>"/>

Contact: Colin Poitras
colin.poitras@uconn.edu
860-486-4656
University of Connecticut
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Clemson chemists discover new way antioxidants fight debilitating diseases
2. Chemists get grip on slippery lipids
3. Good earth: Brown chemists show origin of soil-scented geosmin
4. Team of chemists receives $5 million grant to develop enzyme mimics
5. Biochemists reveal details of mysterious bacterial microcompartments
6. Biologists are from Mars, chemists are from Venus?
7. Glowing films developed by UC San Diego chemists reveal traces of explosives
8. NIST chemists get scoop on crude oil from pig manure
9. Chemists make beds with soft landings
10. Biochemists manipulate fruit flavor enzymes
11. Smoke smudges Mexico Citys air, chemists identify sources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014) Consuming a whole fresh avocado with ... enhanced provitamin A carotenoid (alpha- and beta-carotene) absorption and ... vitamin A, according to new research (1) published ... , Vitamin A is involved in reproductive health ... and vision; and has antioxidant properties. Provitamin A carotenoids, ...
(Date:7/9/2014)... diseases can occur simultaneously in distinct sites in ... effective for one disorder may exacerbate the other. ... which alleviates joint disease but can worsen periodontal ... of The American Journal of Pathology ... anti-arthritic drugs, specifically DTrp8-ɣMSH (DTrp), that acts via ...
(Date:7/9/2014)... one gene for another in a line of living ... reality within this decade. As with any new technology, ... disease-causing genes in humans, for example--as well as questions ... of those concerns to rest: using gene-editing techniques on ... in the cells. The new results were published July ...
Breaking Biology News(10 mins):New research: Fresh avocado enhances absorption of essential nutrients for healthy living 2New class of anti-arthritis drugs effectively treats multiple inflammatory diseases 2No extra mutations in modified stem cells, study finds 2No extra mutations in modified stem cells, study finds 3
... Rebekah E. Gee MD MPH FACOG, Assistant Professor, LSU ... and Medicine, has been chosen to receive a Recognition ... Leadership Award from the Association of Maternal & Child ... vision, and contributions to the health of women, children, ...
... The University of Michigan,s first human embryonic stem cell line ... registry, making the cells available for federally-funded research. It is ... University of Michigan to be placed on the registry. ... derived in October 2010 from a cluster of about 30 ...
... cues from their rivals the honeybees to learn where the ... Mary, University of London. Writing in the journal ... Biological and Chemical Sciences explain how they trained a colony ... by a different species, the honeybee ( Apis mellifera ), ...
Cached Biology News:LSUHSC's Gee honored for improving health of women, children and families 2U-M human embryonic stem cell line placed on national registry 2U-M human embryonic stem cell line placed on national registry 3Bumblebees get by with a little help from their honeybee rivals 2
(Date:1/15/2014)... Two champions of science, technology, engineering, and mathematics ... competition for middle and high school students designed to ... The competition presents students with real-world problems experienced by ... and Sciences is a program administered by the ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider of ... of tinnitus. Patients listen to sound therapy that is ... of weeks to months, their tinnitus volume decreases. , AudioNotch ... Music and Notched White Noise. Now, AudioNotch is pleased to ...
(Date:1/14/2014)... provider of strategic communications services to corporations and organizations preparing for ... United States and Europe , today ... to the firm,s Washington, D.C. office. ... years of service as Associate Commissioner for the Office of External ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management ... Product Strategy. In this role, Michelle will work with current ... in the development of iLab products. Her main goal will ... to the scientific community by offering the most advanced, user-friendly, ...
Breaking Biology Technology:Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Former FDA Associate Commissioner Returns To 3D Communications 2iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
... ... Earned Value Management can improve control over clinical development costs, payments, and accruals and ... , ... June 11, 2009 -- ClearTrial ( www.cleartrial.com ), a leading provider of clinical trial ...
... STAAR Surgical Company (Nasdaq: STAA ), a ... products, today announced that the FDA has granted 510(k) ... the Affinity(TM) Collamer(R) Three-Piece NTIOL and the Elastimide(TM) Silicone ... a new era of insertion devices for the company ...
... June 11 New data from Phase 3 ... (NYSE: WYE ) investigational pneumococcal vaccine, Prevenar 13* ... provide coverage against the 13 most prevalent serotypes associated with ... children younger than five worldwide. , , ...
Cached Biology Technology:ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials 2STAAR Surgical Receives FDA Clearance for the Epiphany(TM) Injector System 2STAAR Surgical Receives FDA Clearance for the Epiphany(TM) Injector System 3New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 2New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 3New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 4New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 5New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 6
...
...
... Ribonuclease III (RNase III) from E. ... double-stranded RNA (dsRNA) to dsRNA fragments that ... dsRNA results in dsRNA fragments of 12-15 ... RNA composed of canonical ribonucleotides as well ...
Mouse monoclonal [6911] to E. coli K99 pilus ( Abpromise for all tested applications)....
Biology Products: